Literature DB >> 22233478

Lateral cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the lateral compartment.

Mubashir G Mulla1, Wolfram Trudo Knoefel, Jackie Gilbert, Alan McGregor, Klaus-Martin Schulte.   

Abstract

BACKGROUND: Papillary thyroid cancer (PTC) is a common endocrine cancer and frequently presents with lymph node (LN) metastases. The frequency of LN metastases in the lateral compartment and their surgical removal are poorly defined. There are no prospective randomised controlled trials addressing an eventual outcome difference relating to the extent of the initial surgical approach. The aim of this study was to define the extent of lateral LN involvement and the role of imaging in identification of these metastatic LN. DESIGN AND METHODS: A systematic review of studies of patients with PTC undergoing either prophylactic or therapeutic lymphadenectomy of the lateral cervical compartment. Studies involving imaging modalities in the detection of lateral cervical LNs in PTC were also analysed.
RESULTS: Systematic review on the frequency of lateral LN metastases and their detection using various imaging tools identified 19 studies containing data on 5587 patients undergoing prophylactic or imaging-guided removal of the lateral compartment. Imaging-guided surgery retrieved cancerous lateral LNs in 446/3178 or 14% of eligible patients, whilst prophylactic lateral neck dissection yielded histopathological proof of cancer in 1177/204 or 57·5% of patients. The frequency of lateral compartment metastases increased with T stage. The sensitivity of ultrasound and CT was poor as low as 27% when accurately calculated.
CONCLUSION: Metastatic cervical LNs were found in more than half of patients when prophylactic lateral LN dissection was performed. Use of conventional imaging for the selection of the surgical approach to the lateral cervical compartment may commonly identify stage N1a instead of N1b and thus lead to false stage assignment as stage III rather than stage IV, concealing the severe prognostic implications of this stage progression in individual patients.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22233478     DOI: 10.1111/j.1365-2265.2012.04336.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  21 in total

1.  Prophylactic level II neck dissection guided by frozen section for clinically node-negative papillary thyroid carcinoma: is it useful?

Authors:  Dana M Hartl; Abir Al Ghuzlan; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Martin Schlumberger
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

Review 2.  Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Authors:  Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

3.  Application of deep learning to the diagnosis of cervical lymph node metastasis from thyroid cancer with CT.

Authors:  Jeong Hoon Lee; Eun Ju Ha; Ju Han Kim
Journal:  Eur Radiol       Date:  2019-03-15       Impact factor: 5.315

4.  Intraoperative diagnosis of central compartment lymph node metastasis predicts recurrence of patients with papillary thyroid carcinoma and clinically node-negative lateral neck and may guide extent of initial surgery.

Authors:  Chang Wook Lee; Gyungyup Gong; Jong-Lyel Roh
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

5.  Intraglandular dissemination is a risk factor for lymph node metastasis in papillary thyroid carcinoma: a propensity score matching analysis.

Authors:  Bei Qian; Shuang Guo; Jun Zhou; Xincai Qu; Shoupeng Zhang
Journal:  Gland Surg       Date:  2021-12

6.  Measurement of thyroglobulin level in lateral neck lymph node fine needle aspiration washout fluid in papillary thyroid cancer.

Authors:  Kwangsoon Kim; Ja Seong Bae; Jeong Soo Kim
Journal:  Gland Surg       Date:  2021-09

7.  Development and validation of web-based nomograms for predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma.

Authors:  Yi Dou; Yingji Chen; Daixing Hu; Wei Xiong; Qi Xiao; Xinliang Su
Journal:  Gland Surg       Date:  2020-04

8.  Is a Prophylactic Central Compartment Neck Dissection Required in Papillary Thyroid Carcinoma Patients with Clinically Involved Lateral Compartment Lymph Nodes?

Authors:  Victoria Harries; Marlena McGill; Laura Y Wang; R Michael Tuttle; Richard J Wong; Ashok R Shaha; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2020-07-17       Impact factor: 5.344

9.  Lateral neck multilevel fine-needle aspiration cytology and thyroglobulin estimation in papillary thyroid carcinoma.

Authors:  Yuntao Song; Guohui Xu; Tianxiao Wang; Bin Zhang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-05-25

10.  Optimal surgical extent of lateral and central neck dissection for papillary thyroid carcinoma located in one lobe with clinical lateral lymph node metastasis.

Authors:  Hyo Sub Keum; Yong Bae Ji; Jong Min Kim; Jin Hyeok Jeong; Woong Hwan Choi; You Hern Ahn; Kyung Tae
Journal:  World J Surg Oncol       Date:  2012-10-25       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.